Back

Chapter review

Chapter 9

Anxiety Disorders

131 topics · 30 traps · 32 safety · 7 car scripts

  1. Scan must-know (one line per topic).
  2. Read every board trap and safety card.
  3. Quiz this chapter, then watch with study-along.
  4. Play car scripts in Speechify or read them here.

Chapter diagrams

Must know

  • Symptom Differentiation (Figure 9-1)Anxiety symptoms manifest in two domains: psychological (apprehension, fear, obsession) and physiological (muscle tension, tachycardia, tachypnea, chest tightness, stomach discomfort, restlessness).
    • Anxiety symptoms manifest in two domains: psychological (apprehension, fear, obsession) and physiological (muscle tension, tachycardia, tachypnea, chest tightness, stomach discomfort, restlessness).
    • Normal anxiety is defined as a proportional response to a real external threat that does not impair daily function.
    • Anxiety disorders (pathological anxiety) are defined by excessive responses or threat-free onset combined with significant functional impairment.
    • Medical conditions that mimic anxiety symptoms span cardiovascular (myocardial infarction), respiratory (COPD, pulmonary embolism), and metabolic (hypoglycemia, pheochromocytoma) systems.
    • Pharmacological triggers of anxiety include stimulants, sympathomimetics, theophylline, diphenhydramine (paradoxical excitation in older adults), levodopa, and antipsychotic-induced akathisia.
    • Generalized anxiety disorder requires excessive worry on most days for at least 6 months plus 3 of 6 physical/cognitive symptoms in adults (1 in children), whereas panic attack surges peak within 10 minutes.
  • Which of the following symptoms is not consistent with a panic attack?A. Sensation of shortness of breath
    • A. Sensation of shortness of breath
    • C. Fear of dying
  • The Diagnostic Pivot LogicNormal anxiety is a reasonable, adaptive response to a real external threat, whereas anxiety disorder requires an excessive response or no external threat plus demonstrable functional impairment.
    • Normal anxiety is a reasonable, adaptive response to a real external threat, whereas anxiety disorder requires an excessive response or no external threat plus demonstrable functional impairment.
    • Gate 1 (Medical Rule-Out): Always rule out physiological mimics first, including hyperthyroidism, pheochromocytoma, COPD, pulmonary embolism, myocardial infarction, and hypoglycemia.
    • Gate 2 (Substance Rule-Out): Evaluate for symptoms starting within 1 month of substance use, intoxication, or withdrawal. Key culprits include theophylline, diphenhydramine, levodopa, stimulants, and withdrawal from alcohol or benzodiazepines.
    • Gate 3 (Stressor Timeline): Symptoms emerging within 3 months of an identified stressor that resolve within 6 months after termination represent adjustment disorder.
    • Gate 4 (Trauma Pivot): Symptoms developing after severe trauma lasting 3 days to 1 month are acute stress disorder (ASD); symptoms persisting greater than 1 month become post-traumatic stress disorder (PTSD).
    • Gate 5 (Primary Chronic Disorders): Generalized anxiety disorder (GAD) requires excessive worry on most days for 6 months or more with 3 or more WATCHERS symptoms (1 symptom in children). Panic disorder requires recurrent, unexpected attacks peaking within 10 minutes, followed by 1 month of anticipatory worry or behavioral change.
  • Step 1: Normal vs. Pathological AnxietyIs there an actual external threat?
    • Is there an actual external threat?
    • Is the autonomic and emotional response proportional to the threat?
    • Is there significant impairment in social, occupational, or personal functioning?
  • Step 2: The 5-Gate Diagnostic FilterNever diagnose a primary psychiatric anxiety disorder without running the patient through the systematic 5-gate filter. Missing an underlying medical crisis or drug toxicity can be fatal.
    • Never diagnose a primary psychiatric anxiety disorder without running the patient through the systematic 5-gate filter. Missing an underlying medical crisis or drug toxicity can be fatal.
    • 1. Gate 1: Rule Out Medical Conditions
    • Assess for medical mimics before considering primary psychiatric illness.
    • Endocrine and metabolic triggers: hyperthyroidism, pheochromocytoma, and hypoglycemia (which triggers sympathoadrenal epinephrine release).
    • Cardiopulmonary triggers: myocardial infarction, COPD, and pulmonary embolism.
    • 2. Gate 2: Rule Out Substance and Medication Triggers

    Safety. Never diagnose a primary psychiatric anxiety disorder without running the patient through the systematic 5-gate filter. Missing an underlying medical crisis or drug toxicity can be fatal.

  • Compare and DistinguishNormal Anxiety vs. Anxiety Disorder
    • Normal Anxiety vs. Anxiety Disorder
    • Think: Normal anxiety is adaptive and proportional; anxiety disorder is excessive and disabling.
    • Priority: Differentiate real external threat from pathologically generated hyperarousal.
    • Boards are testing: Functional impairment as the defining threshold for psychiatric diagnosis.
    • Acute Stress Disorder vs. Post-Traumatic Stress Disorder
    • Think: The 1-month calendar cutoff determines the diagnostic label.

    Board trap. Test writers love presenting an older adult with acute anxiety who was recently started on diphenhydramine or theophylline, or a patient with new-onset panic who is actually experiencing hypoglycemia or hyperthyroidism. Selecting a primary anxiety disorder or prescribing an SSRI before completing Gate 1 and Gate 2 medical and medication rule-outs is a classic distractor trap.

  • C) MethotrexateWhy It Is Correct: Methotrexate is an immunosuppressive disease-modifying antirheumatic agent that does not cause central nervous system stimulation or autonomic hyperarousal, making it least likely to induce anxiety symptoms.
    • Why It Is Correct: Methotrexate is an immunosuppressive disease-modifying antirheumatic agent that does not cause central nervous system stimulation or autonomic hyperarousal, making it least likely to induce anxiety symptoms.
    • Why the Other Choices Are Wrong:
    • A: Theophylline is a xanthine bronchodilator with central stimulant properties that commonly causes tachycardia, tremors, and severe anxiety.
    • B: Diphenhydramine has significant anticholinergic effects that frequently trigger paradoxical central nervous system excitation, restlessness, and anxiety in older adults.
    • D: Levodopa increases central dopamine levels, which routinely causes agitation, anxiety, and neuro-psychiatric side effects.
  • C) HyperglycemiaWhy It Is Correct: Hyperglycemia does not acutely stimulate the sympathoadrenal system to produce acute panic or autonomic anxiety symptoms, whereas hypoglycemia triggers an immediate catecholamine surge.
    • Why It Is Correct: Hyperglycemia does not acutely stimulate the sympathoadrenal system to produce acute panic or autonomic anxiety symptoms, whereas hypoglycemia triggers an immediate catecholamine surge.
    • Why the Other Choices Are Wrong:
    • A: Chronic obstructive pulmonary disease causes acute hypoxia and hypercapnia, which directly trigger respiratory panic and intense autonomic anxiety.
    • B: Myocardial infarction induces severe autonomic hyperarousal and acute apprehension, often described as a feeling of impending doom.
    • D: Hypoglycemia triggers a massive epinephrine release, causing acute tachycardia, diaphoresis, tremors, and severe anxiety.
  • D) I am terrified that another attack will happen so I avoid leaving my apartment aloneWhy It Is Correct: Panic disorder requires recurrent, unexpected panic attacks that occur spontaneously out of the blue. Attacks that occur predictably after a specific emotional argument are situational responses rather than unexpected panic.
    • Why It Is Correct: Panic disorder requires recurrent, unexpected panic attacks that occur spontaneously out of the blue. Attacks that occur predictably after a specific emotional argument are situational responses rather than unexpected panic.
    • Why the Other Choices Are Wrong:
    • B: Depersonalization and derealization are characteristic psychological symptoms during a panic attack.
    • C: Abrupt onset peaking within 10 minutes out of the blue is the cardinal feature of unexpected panic attacks.
    • D: Persistent anticipatory worry and behavioral avoidance lasting 1 month or more are core criteria for panic disorder.
  • D) The diagnosis cannot be made until symptoms have persisted for at least 6 monthsWhy It Is Correct: Symptoms occurring between 3 days and 1 month following exposure to a severe traumatic event meet the specific time frame for acute stress disorder.
    • Why It Is Correct: Symptoms occurring between 3 days and 1 month following exposure to a severe traumatic event meet the specific time frame for acute stress disorder.
    • Why the Other Choices Are Wrong:
    • A: The diagnosis of post-traumatic stress disorder requires symptoms to persist for greater than 1 month, regardless of trauma severity or type.
    • C: Adjustment disorder is used for non-trauma stressors or trauma reactions that do not meet full symptom criteria for ASD or PTSD.
    • D: PTSD can be diagnosed as soon as symptom duration exceeds 1 month; waiting 6 months is unnecessary.
  • Diagnostic Branching Hierarchy (Figure 9-2)Gate 1 Medical Rule-Out: Before diagnosing a primary psychiatric disorder, rule out medical conditions such as hyperthyroidism, pheochromocytoma, COPD, pulmonary embolism, myocardial infarction, and hypoglycemia.
    • Gate 1 Medical Rule-Out: Before diagnosing a primary psychiatric disorder, rule out medical conditions such as hyperthyroidism, pheochromocytoma, COPD, pulmonary embolism, myocardial infarction, and hypoglycemia.
    • Gate 2 Substance Rule-Out: Substance-induced anxiety disorder is diagnosed when symptoms occur within 1 month of substance ingestion, intoxication, or withdrawal. Key offending agents include sympathomimetics, stimulants, theophylline, levodopa, diphenhydramine, and withdrawal from alcohol or benzodiazepines.
    • Gate 3 Adjustment Disorder: Adjustment disorder with anxious mood requires symptom onset within 3 months of an identifiable stressor and resolution within 6 months after the stressor or its consequences end.
    • Gate 4 Trauma Timeline: Trauma-related symptoms lasting 3 days to 1 month after exposure represent acute stress disorder. Symptoms persisting for greater than 1 month represent post-traumatic stress disorder (PTSD).
    • Gate 4 GAD Criteria: Generalized anxiety disorder (GAD) requires excessive, uncontrollable worry on most days for at least 6 months, accompanied by at least 3 of the WATCHERS physical/cognitive symptoms (only 1 symptom required in children).
    • Gate 4 Panic Disorder Criteria: Panic disorder requires recurrent, unexpected panic attacks peaking within 10 minutes, followed by at least 1 month of persistent concern about additional attacks or significant maladaptive behavior change.
  • Step 1: Primary Medical Assessment (Gate 1)What it is: Evaluating whether physical illness or altered lab parameters directly cause the anxiety presentation.
    • What it is: Evaluating whether physical illness or altered lab parameters directly cause the anxiety presentation.
    • Check TSH for hyperthyroidism, EKG and cardiac enzymes for myocardial infarction, blood glucose for hypoglycemia, and urinary catecholamines for pheochromocytoma.
    • Never assume acute anxiety or panic in an older adult or new-onset case is primary psychiatric without obtaining vital signs, physical exam, and basic lab work.
    • Mistaking physical symptoms of hypoxia or respiratory distress from COPD or pulmonary embolism for a primary panic attack.

    Board trap. Mistaking physical symptoms of hypoxia or respiratory distress from COPD or pulmonary embolism for a primary panic attack.

    Safety. Never assume acute anxiety or panic in an older adult or new-onset case is primary psychiatric without obtaining vital signs, physical exam, and basic lab work.

  • Step 2: Substance and Medication Assessment (Gate 2)What it is: Identifying anxiety caused by exogenous substances, prescriptions, or withdrawal.
    • What it is: Identifying anxiety caused by exogenous substances, prescriptions, or withdrawal.
    • Timelines: Symptoms occur within 1 month of substance use, intoxication, or discontinuation.
    • Common offending drugs: theophylline, bronchodilators, levodopa, diphenhydramine, OTC decongestants, caffeine, amphetamines, and abrupt withdrawal from benzodiazepines or alcohol.
    • Abrupt discontinuation of alprazolam or lorazepam can precipitate severe withdrawal seizures, delirium, and autonomic crisis.
    • Attributing new-onset agitation in a Parkinson patient to worsening anxiety instead of levodopa toxicity or akathisia from antipsychotics.

    Board trap. Attributing new-onset agitation in a Parkinson patient to worsening anxiety instead of levodopa toxicity or akathisia from antipsychotics.

    Safety. Abrupt discontinuation of alprazolam or lorazepam can precipitate severe withdrawal seizures, delirium, and autonomic crisis.

  • Step 3: Stressor and Adjustment Assessment (Gate 3)What it is: Evaluating emotional or behavioral reactions to identifiable psychosocial stressors.
    • What it is: Evaluating emotional or behavioral reactions to identifiable psychosocial stressors.
    • Timelines: Onset occurs within 3 months of the stressor. Symptoms must resolve within 6 months once the stressor or its consequences end.
    • Distress is out of proportion to the stressor severity and causes functional impairment, but does not meet full criteria for another primary disorder.
  • Step 4: Primary Anxiety and Related Disorders Screening (Gate 4: The Big Five)SSRIs (sertraline, paroxetine) or SNRIs plus trauma-focused psychotherapy. Prazosin (3 to 15 mg) at bedtime targets trauma nightmares. Avoid benzodiazepines in PTSD.
    • Trauma spectrum:
    • Acute stress disorder: Symptoms emerge within 3 days to 1 month following exposure to actual or threatened death, serious injury, or sexual violence.
    • Post-traumatic stress disorder: Symptoms persist for greater than 1 month post-trauma, spanning intrusion, avoidance, negative mood/cognitions, and hyperarousal.
    • SSRIs (sertraline, paroxetine) or SNRIs plus trauma-focused psychotherapy. Prazosin (3 to 15 mg) at bedtime targets trauma nightmares. Avoid benzodiazepines in PTSD.
    • Social and phobic spectrum:
    • Social anxiety disorder: Marked fear of scrutiny or embarrassment in social or performance situations lasting at least 6 months.

    Board trap. A panic attack is a specifier, not a standalone DSM-5-TR diagnosis.

  • Step 5: Unspecified Classification (Gate 5)What it is: Used when anxiety symptoms cause significant functional impairment but fail to meet full diagnostic thresholds for any specific primary disorder.
    • What it is: Used when anxiety symptoms cause significant functional impairment but fail to meet full diagnostic thresholds for any specific primary disorder.

Board traps

  • Compare and Distinguish

    Test writers love presenting an older adult with acute anxiety who was recently started on diphenhydramine or theophylline, or a patient with new-onset panic who is actually experiencing hypoglycemia or hyperthyroidism. Selecting a primary anxiety disorder or prescribing an SSRI before completing Gate 1 and Gate 2 medical and medication rule-outs is a classic distractor trap.

  • Step 1: Primary Medical Assessment (Gate 1)

    Mistaking physical symptoms of hypoxia or respiratory distress from COPD or pulmonary embolism for a primary panic attack.

  • Step 2: Substance and Medication Assessment (Gate 2)

    Attributing new-onset agitation in a Parkinson patient to worsening anxiety instead of levodopa toxicity or akathisia from antipsychotics.

  • Step 4: Primary Anxiety and Related Disorders Screening (Gate 4: The Big Five)

    A panic attack is a specifier, not a standalone DSM-5-TR diagnosis.

  • Medical and Pharmacological Mimics (Table 9-1)

    Distinguish medication-induced akathisia from worsening primary anxiety. Akathisia is an extrapyramidal motor restlessness caused by dopamine-blocking antipsychotics or antiemetics that patients experience as extreme internal anxiety.

  • Generalized Anxiety Disorder (GAD) Criteria

    Up to 75 percent of patients present in primary care with somatic complaints rather than explicit worry, and 50 to 90 percent have a comorbid psychiatric disorder such as major depressive disorder.

  • Epidemiology, Etiology, and Clinical Presentation

    Clinicians must remember that 75 percent of patients with generalized anxiety disorder seek medical care for physical or somatic complaints such as muscle aches, gastrointestinal distress, or chronic fatigue rather than psychiatric distress. Furthermore, 50 to 90 percent of patients carry a comorbid psychiatric diagnosis, most commonly major depressive disorder or substance use disorders, and 25 percent eventually experience panic disorder. Because patients often cope for years before seeking treatment, chronic worry can exhaust neural circuits and lead to secondary depression.

  • Diagnostic Criteria and Timelines

    Do not confuse GAD with adjustment disorder with anxious mood. Adjustment disorder symptoms develop within 3 months of a specific stressor and last no longer than 6 months after the stressor resolves. GAD requires 6 or more months of pervasive worry without requiring an acute precipitating stressor.

Safety alerts

  • Step 2: The 5-Gate Diagnostic Filter

    Never diagnose a primary psychiatric anxiety disorder without running the patient through the systematic 5-gate filter. Missing an underlying medical crisis or drug toxicity can be fatal.

  • Step 1: Primary Medical Assessment (Gate 1)

    Never assume acute anxiety or panic in an older adult or new-onset case is primary psychiatric without obtaining vital signs, physical exam, and basic lab work.

  • Step 2: Substance and Medication Assessment (Gate 2)

    Abrupt discontinuation of alprazolam or lorazepam can precipitate severe withdrawal seizures, delirium, and autonomic crisis.

  • Medical and Pharmacological Mimics (Table 9-1)

    Suspect pheochromocytoma when a patient presents with paroxysmal episodes of severe hypertension, headache, diaphoresis, and sudden panic attacks due to catecholamine hypersecretion.

  • Generalized Anxiety Disorder (GAD) Criteria

    Always rule out medical mimics such as hyperthyroidism and substance-induced anxiety before establishing a primary psychiatric diagnosis.

  • Treatment Strategy and Psychopharmacology

    Cautiously consider initiating psychotropic medications on the very first visit. Patients with severe anxiety frequently read medication package inserts thoroughly and may reject treatment if they experience transient initial activation or side effects. Start at a low dose, such as half the standard starting dose, and titrate slowly.

  • Diagnostic Criteria and Timelines

    Always rule out general medical conditions like hyperthyroidism or pheochromocytoma, as well as substance-induced anxiety, before confirming a primary GAD diagnosis.

  • Psychopharmacology and Safety Rules

    When discontinuing long-term benzodiazepines like alprazolam, taper no faster than 0.25 mg per week. Abrupt cessation risks rebound anxiety, severe withdrawal, seizures, delirium, and death. Tapering can also be facilitated by substituting an equivalent dose of a long-acting agent like diazepam.

Compare and distinguish

No compare cards in this pack.

Memory hooks

No memory hooks in this pack.

Car scripts